Why Is Drug Pricing Higher In US? Study Takes Aim At R&D Argument

Amgen, Biogen, Pfizer and Teva generated more than twice their global R&D budgets with higher pricing in the US compared to Western Europe and Canada, researchers at Memorial Sloan Kettering found.

PharmacyReceipt-Dollars-PillBottles_1200x675

More from Pricing Debate

More from Market Access